This guy better get Remplir over the line with the FDA in six months via a more lucrative route than 510K or he is ridiculously, ridiculously over valued.
I couldn't help myself. Sent some of the more aggrieved responses above to PA. The frustration is appropriate.
This award akin to some of the silly starting awards of sought after executives in the USA in 2020/21 in fledgling tech start ups. This iis Australia not Disneyland. That award is Mickey Mouse. He'd better bring us as shareholders to the land of Fantasia.
Ann: Orthocell Appoints Non-Executive Director Dr Ravi Thadhani, page-21
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
-0.005(1.35%) |
Mkt cap ! $76.49M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.5¢ | $52.06K | 142.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 20235 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 4244 | 1 |
View Market Depth
| Last trade - 14.42pm 20/08/2024 (20 minute delay) ? |
| OCC (ASX) Chart |